Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Agenus Inc’s stock clocked out at $3.68, down -21.37% from its previous closing price of $4.68. In other words, the price has decreased by -$21.37 from its previous closing price. On the day, 3.17 million shares were traded. AGEN stock price reached its highest trading level at $4.83 during the session, while it also had its lowest trading level at $3.61.
Ratios:
To gain a deeper understanding of AGEN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.47 and its Current Ratio is at 0.47.
On July 19, 2024, Robert W. Baird Downgraded its rating to Neutral which previously was Outperform and also lowered its target price recommendation from $35 to $8.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 29 ’25 when Agenus Inc. bought 786,750 shares for $15.98 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AGEN now has a Market Capitalization of 125150720 and an Enterprise Value of 161107728. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.05. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.17. Its current Enterprise Value per Revenue stands at 1.508 whereas that against EBITDA is -3.204.
Stock Price History:
The Beta on a monthly basis for AGEN is 1.63, which has changed by 0.34482753 over the last 52 weeks, in comparison to a change of 0.15507638 over the same period for the S&P500. Over the past 52 weeks, AGEN has reached a high of $7.34, while it has fallen to a 52-week low of $1.38. The 50-Day Moving Average of the stock is -6.04%, while the 200-Day Moving Average is calculated to be -11.16%.
Shares Statistics:
It appears that AGEN traded 583.82K shares on average per day over the past three months and 788910 shares per day over the past ten days. A total of 32.81M shares are outstanding, with a floating share count of 32.34M. Insiders hold about 4.91% of the company’s shares, while institutions hold 22.87% stake in the company. Shares short for AGEN as of 1767139200 were 3399217 with a Short Ratio of 5.82, compared to 1764288000 on 1772528. Therefore, it implies a Short% of Shares Outstanding of 3399217 and a Short% of Float of 10.08.
Earnings Estimates
A comprehensive evaluation of Agenus Inc (AGEN) is underway, with the input of 2.0 analysts contributing to its current rating.The consensus estimate for the next quarter is $1.8, with high estimates of $1.8 and low estimates of $1.8.
Analysts are recommending an EPS of between -$3.85 and -$3.85 for the fiscal current year, implying an average EPS of -$3.85. EPS for the following year is $1.96, with 2.0 analysts recommending between $3.41 and $0.5.
Revenue Estimates
In. The current quarter, 3 analysts expect revenue to total $53.1M. It ranges from a high estimate of $105.2M to a low estimate of $26.09M. As of. The current estimate, Agenus Inc’s year-ago sales were $26.84MFor the next quarter, 3 analysts are estimating revenue of $65.8M. There is a high estimate of $101.4M for the next quarter, whereas the lowest estimate is $30.2M.
A total of 3 analysts have provided revenue estimates for AGEN’s current fiscal year. The highest revenue estimate was $185.2M, while the lowest revenue estimate was $106.08M, resulting in an average revenue estimate of $133.09M. In the same quarter a year ago, actual revenue was $103.46MBased on 3 analysts’ estimates, the company’s revenue will be $154.52M in the next fiscal year. The high estimate is $232M and the low estimate is $110.67M.
